Maintenance Notice (10:30 PM January 4 - 8:00 AM January 5, 2025 UTC): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.197 | Notice of Discontinuing the Use of Password-Protected Compressed Files | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 4342-03-4 | Product Number: D3634
Dacarbazine
×
![]()
×
Purity: >98.0%(T)(HPLC)
Synonyms:
- DTIC
- 5-(3,3-Dimethyltriazeno)imidazole-4-carboxamide
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
|
|---|---|---|---|---|---|
| 1G |
₩146,200
|
14 | 3 | Contact Us | |
| 5G |
₩423,700
|
3 | 0 | Contact Us |
* Please contact our distributor of SEJIN CI Co., Ltd.
if you would like to purchase TCI products. The above prices do not include freight cost, customs charge and other charges to the destination. SEJIN CI Co., Ltd. (Phone: 02-2655-2480 / email:
sales@sejinci.co.kr)
* The storage conditions are subject to change without notice.
* The storage conditions are subject to change without notice.
| Product Number | D3634 |
| Purity / Analysis Method | >98.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__6H__1__0N__6O = 182.19 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Refrigerated (0-10°C) |
| Condition to Avoid | Light Sensitive,Heat Sensitive |
| Packaging and Container | 1G-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 4342-03-4 |
| Reaxys Registry Number | 521487 |
| PubChem Substance ID | 87560054 |
| Merck Index (14) | 2798 |
| MDL Number | MFCD00057167 |
Specifications
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
Properties (reference)
| Melting Point | 255 °C(dec.) |
GHS
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H315 : Causes skin irritation. H319 : Causes serious eye irritation. H351 : Suspected of causing cancer. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. P405 : Store locked up. |
Related Laws:
| RTECS# | NI3950000 |
Transport Information:
| H.S.code* | 2933.29-000 |
Application
Dacarbazine: A Triazene Alkylating Agent with Antitumor and Mutagenic Properties
Dacarbazine (DTIC) is a triazene alkylating agent with antitumor and mutagenic properties, such as temozolomide [T2744]. DTIC is a prodrug that is metabolized to 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (MTIC) which serves to transport a methylating agent (diazomethane) to the O 6 position of guanine within the major groove of DNA that generate base/base mismatches with cytosine and with thymine. These adduct lead to cell death, or if the cell survives, provoke mutations in DNA helix. DTIC is used for the treatment of melanoma. (The product is for research purpose only.)
References
- Antitumor imidazotetrazines. XXIII. Comparison of the cytotoxicity in vitro of temozolomide and dacarbazine, prodrugsof 3-methyl(triazen-1-yl)imidazole-4-carboxamide
- Dacarbazine-based chemotherapy for metastatic melanoma: Thirty-year experience overview (a review)
- Re-evaluating the role of dacarbazine in metastatic melanoma: what have we learned in 30 years? (a review)
- Triazene compounds: Mechanism of action and related DNA repair systems
- Ipilimumab plus dacarbazine for previously untreated metastatic melanoma
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.